Aerosolization characteristics of dry powder inhaler formulations for the excipient enhanced growth (EEG) application: effect of spray drying process conditions on aerosol performance
about
Evaluation and modification of commercial dry powder inhalers for the aerosolization of a submicrometer excipient enhanced growth (EEG) formulationTargeted Lung Delivery of Nasally Administered AerosolsTargeting aerosol deposition to and within the lung airways using excipient enhanced growthDevelopment of high efficiency ventilation bag actuated dry powder inhalers.Development of a new technique for the efficient delivery of aerosolized medications to infants on mechanical ventilationEfficient Nose-to-Lung (N2L) Aerosol Delivery with a Dry Powder Inhaler.Characterization of a New High-Dose Dry Powder Inhaler (DPI) Based on a Fluidized Bed Design.Aerodynamic factors responsible for the deaggregation of carrier-free drug powders to form micrometer and submicrometer aerosols.Development of a high efficiency dry powder inhaler: effects of capsule chamber design and inhaler surface modifications.Development and comparison of new high-efficiency dry powder inhalers for carrier-free formulations.Dry powder inhalation: past, present and future.Spray-dried particles as pulmonary delivery system of anti-tubercular drugs: design, optimization, in vitro and in vivo evaluation.Whether a novel drug delivery system can overcome the problem of biofilms in respiratory diseases?Aerosol Drug Delivery During Noninvasive Positive Pressure Ventilation: Effects of Intersubject Variability and Excipient Enhanced Growth.Development of an Inline Dry Power Inhaler That Requires Low Air Volume.An Inhalable Powder Formulation Based on Micro- and Nanoparticles Containing 5-Fluorouracil for the Treatment of Metastatic Melanoma.
P2860
Q28387314-8ECA846F-FA74-4E6D-8EF9-6A4C383F69D7Q28387568-63CC7AB4-D37E-428C-832E-2AD1122748CAQ28390979-6B38D3D7-B8E4-4E7D-A3B9-30567BC6CA5FQ33732483-01F734CC-9679-4E31-90AB-6256A91D9DC9Q34861310-893E4B3C-9FD3-4A07-89CB-D2D16D163B31Q36024362-25DDEA3E-5243-4A52-8E3F-E8D885C109C4Q36200226-5C9C0C3D-2381-44C9-9E37-C617F1ED8A76Q36989479-42D73177-BE00-4752-A054-8BD1AEE26BDCQ37625308-BAD4019C-CD81-4C70-A8C2-A90FAC688116Q37626575-03E2B2EF-E0E6-408B-9B92-110BA014622FQ38830375-71ECBDE4-F3DC-4790-8F23-8E05B6566200Q38967890-A33127FF-3B31-4512-A7B1-AE360BEB1D7BQ39031123-5C284283-D0B0-4F29-81B7-79A59CB91167Q45050545-6F688C94-4D63-4DD3-93EC-B294BC39256CQ47231446-849E23EC-A86D-4EF0-A469-12A12CD5B4ADQ48132700-3775FEC0-A268-463D-964C-7FA039471E7B
P2860
Aerosolization characteristics of dry powder inhaler formulations for the excipient enhanced growth (EEG) application: effect of spray drying process conditions on aerosol performance
description
2013 nî lūn-bûn
@nan
2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Aerosolization characteristics ...... ditions on aerosol performance
@ast
Aerosolization characteristics ...... ditions on aerosol performance
@en
Aerosolization characteristics ...... ditions on aerosol performance
@nl
type
label
Aerosolization characteristics ...... ditions on aerosol performance
@ast
Aerosolization characteristics ...... ditions on aerosol performance
@en
Aerosolization characteristics ...... ditions on aerosol performance
@nl
prefLabel
Aerosolization characteristics ...... ditions on aerosol performance
@ast
Aerosolization characteristics ...... ditions on aerosol performance
@en
Aerosolization characteristics ...... ditions on aerosol performance
@nl
P2093
P2860
P1476
Aerosolization characteristics ...... ditions on aerosol performance
@en
P2093
Michael Hindle
P Worth Longest
Yoen-Ju Son
P2860
P304
P356
10.1016/J.IJPHARM.2013.01.003
P407
P577
2013-02-25T00:00:00Z